Innovative Bladder Cancer Trials Presented at EAU 2026 Congress for Enhanced Patient Care #Norway #Oslo #Bladder_Cancer #Photocure #Hexvix
Photocure's Innovative Trials at EAU 2026 Focus on Tailored Bladder Cancer Treatments #Norway #Oslo #Bladder_Cancer #Photocure #EAU_2026
Promising Phase 1 Results for Erda-iDRS in Bladder Cancer Patients Show High Response Rate #United_States #Johnson_&_Johnson #Raritan #Bladder_Cancer #Erda-iDRS
ImmVira Presents Promising MVR-T3011 Data for Bladder Cancer at ASCO GU 2026 #China #Suzhou #Bladder_Cancer #ImmVira #MVR-T3011
CorePlus and AIxMED Revolutionize Bladder Cancer Detection with AI-Driven Technology #United_States #San_Juan #Bladder_Cancer #CorePlus #AIxMed
Innovative Cancer Treatment: PADCEV Plus Keytruda Boosts Survival in Bladder Cancer Patients #Japan #Tokyo #KEYTRUDA #PADCEV #Bladder_Cancer
Blue Light Cystoscopy's Economic Advantage Explored in BRAVO Study Findings #Norway #Oslo #Bladder_Cancer #Photocure_ASA #Blue_Light_Cystoscopy
The BRAVO Study: Cost Neutrality in Cystoscopy for Bladder Cancer Patients Presented at SUO 2025 #Norway #Oslo #Bladder_Cancer #Photocure_ASA #BRAVO_Study
Johnson & Johnson's INLEXZO™ Shows Promising Results for Treating High-Risk Bladder Cancer #United_States #Johnson_&_Johnson #Raritan #Bladder_Cancer #INLEXZO™
New Study Highlights Economic Benefits of Blue Light Cystoscopy in Managing Bladder Cancer Across Europe #Norway #Oslo #Bladder_Cancer #Photocure #BLC
Photocure and Intelligent Scopes Unveil AI-Driven Solutions for Enhanced Bladder Cancer Diagnosis #Norway #Oslo #Bladder_Cancer #Photocure #Intelligent_Scopes
FDA Approves INLEXZO™: A Breakthrough in Bladder Cancer Treatment Options #United_States #Johnson_&_Johnson #Bladder_Cancer #INLEXZO™ #RARITAN,_N.J.
Hamlet BioPharma Completes Alpha1H Phase II Study in Bladder Cancer #Sweden #Lund #Bladder_Cancer #Alpha1H #Hamlet_BioPharma
BCAN Extends Support to Deion Sanders Following His Bladder Cancer Diagnosis #United_States #Bethesda #Deion_Sanders #Bladder_Cancer #BCAN
Understanding Bladder Cancer: Symptoms, Risk Factors, and Importance of Early Diagnosis #United_States #Aurora #Bladder_Cancer #University_of_Colorado #Urologic_Oncology
Johnson & Johnson's TAR-200: Pioneering the Future of Bladder Cancer Treatment with FDA Review #USA #New_Jersey #Johnson_&_Johnson #Bladder_Cancer #TAR-200
BCAN Announces $1 Million Grant to Propel Bladder Cancer Research Forward #United_States #Bethesda #Bladder_Cancer #BCAN #Research_Grant
TOBY's Breakthrough AI-Powered Urine Test for Bladder Cancer Gains FDA Approval #United_States #Boston #Bladder_Cancer #TOBY_Inc #AI_Urine_Test
Tyra Biosciences Begins Phase 2 Trial of TYRA-300 for Bladder Cancer #United_States #Carlsbad #Tyra_Biosciences #TYRA-300 #Bladder_Cancer
ImmVira Begins Phase II Trial of Oncolytic Therapy for Bladder Cancer #China #Suzhou #Bladder_Cancer #ImmVira #MVR-T3011
Photocure ASA Reports Strong Growth in Q1 2025 with Boost in Bladder Cancer Product Sales #Norway #Oslo #Bladder_Cancer #Photocure #Hexvix
Photocure ASA Reports Strong Financial Results for Q1 2025 with Continued Growth in Bladder Cancer Treatments #Norway #Oslo #Bladder_Cancer #Photocure_ASA #Hexvix
Bladder Cancer Awareness Month: The Time to Act Is Now for Detection and Awareness #United_States #Bethesda #Bladder_Cancer #BCAN #Awareness_Month
AUA2025: Advances in Bladder Cancer Management with Blue Light Cystoscopy #Las_Vegas #Norway #Bladder_Cancer #Photocure_ASA #Blue_Light_Cystoscopy
Johnson & Johnson's TAR-200 Monotherapy Shows Promising Long-Term Efficacy in Bladder Cancer Treatment #USA #Johnson_&_Johnson #Las_Vegas #Bladder_Cancer #TAR-200
Johnson & Johnson Presents Groundbreaking Findings on Bladder Cancer Treatment at AUA 2025 #USA #Johnson_&_Johnson #Las_Vegas #Bladder_Cancer #TAR-200
BCAN Partners with Ferring and Astellas/Pfizer for Bladder Cancer Walks in 2025 #United_States #Bethesda #Bladder_Cancer #Ferring_Pharmaceuticals #Astellas_Pfizer
Photocure Embraces Change with the Appointment of Jane Healy as New VP and GM for EMEA #Norway #Oslo #Bladder_Cancer #Photocure #Jane_Healy
Jane Healy Takes on Leadership Role at Photocure as EMEA General Manager #Norway #Oslo #Bladder_Cancer #Photocure #Jane_Healy
Ractigen's RAG-01 Demonstrates Early Efficacy in Bladder Cancer Trial Presented at EAU 2025 #China #Bladder_Cancer #Ractigen #RAG-01 #Nantong